PHBI

Pharmagreen Biotech Inc.

USD

Set alert

Price alert · PHBI

All alert types
1.17 USD 0.00 0.00%
As of Oct 12, 2026
1.17 Day range 1.17
0.0003 52-week range 7.00
YTD
-35.00%
1 year
-35.00%
Open
1.17
Prev close
1.17
Mkt cap
404.44K
Vol
0
Avg vol
373
EPS
-0.00173
P/E
-676.30
More statistics
Low
1.17
High
1.17

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for PHBI has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-48.39 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 3.3×
FY 2009: -7.7×FY 2017: -29.8×FY 2018: -67.0×FY 2019: -167×FY 2020: -2.7×FY 2021: -1.8×FY 2022: -4.5×FY 2023: -0.6×FY 2024: -2.8×FY 2025: 3.3×
FY 2009 5y median -1.8× FY 2025
P/S 278×
FY 2009: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 109×FY 2024: 812×FY 2025: 278×
FY 2009 5y median 109× FY 2025
P/B -0.3×
FY 2009: -47.2×FY 2017: -372×FY 2018: -51.9×FY 2019: -178×FY 2020: -2.3×FY 2021: -4.9×FY 2022: -2.3×FY 2023: -0.2×FY 2024: -0.9×FY 2025: -0.3×
FY 2009 5y median -0.9× FY 2025
P/FCF -28.5×
FY 2009: -8.8×FY 2017: -1298×FY 2018: -69.4×FY 2019: -288×FY 2020: -10.8×FY 2021: -39.2×FY 2022: -9.5×FY 2023: -4.4×FY 2024: -98.6×FY 2025: -28.5×
FY 2009 5y median -28.5× FY 2025
EV/EBITDA -3.5×
FY 2009: -7.7×FY 2017: 0.0×FY 2018: -179×FY 2019: 23432×FY 2020: -5.5×FY 2021: -2.8×FY 2022: 18.1×FY 2023: 26.8×FY 2024: 17172×FY 2025: -3.5×
FY 2009 5y median 18.1× FY 2025
EV/Sales 427×
FY 2009: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 233×FY 2024: 917×FY 2025: 427×
FY 2009 5y median 233× FY 2025
FCF Yield -3.5%
FY 2009: -11.4%FY 2017: -0.1%FY 2018: -1.4%FY 2019: -0.3%FY 2020: -9.3%FY 2021: -2.6%FY 2022: -10.6%FY 2023: -22.6%FY 2024: -1.0%FY 2025: -3.5%
FY 2009 5y median -3.5% FY 2025

Profitability

Gross Margin -16.8%
FY 2009: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -215.0%FY 2024: 50.9%FY 2025: -16.8%
FY 2009 5y median 0.0% FY 2025
Operating Margin -12164.7%
FY 2009: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -15810.5%FY 2024: -7272.7%FY 2025: -12164.7%
FY 2009 5y median -7272.7% FY 2025
Net Margin 17016.9%
FY 2009: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -18979.3%FY 2024: -29442.8%FY 2025: 17016.9%
FY 2009 5y median 0.0% FY 2025
ROE -15.4%
FY 2009: 613.9%FY 2017: 21.7%FY 2018: 77.4%FY 2019: 92.2%FY 2020: 84.4%FY 2021: 275.3%FY 2022: 49.3%FY 2023: 26.7%FY 2024: 32.5%FY 2025: -15.4%
FY 2009 5y median 32.5% FY 2025
ROIC 12.5%
FY 2009: 812.6%FY 2017: -1.3%FY 2018: 48.3%FY 2019: 85.5%FY 2020: 37.9%FY 2021: 52.9%FY 2022: 72.1%FY 2023: 26.2%FY 2024: 8.9%FY 2025: 12.5%
FY 2009 5y median 26.2% FY 2025
ROA 5387.3%
FY 2009: 0.0%FY 2017: -483.0%FY 2018: -239.0%FY 2019: -121.9%FY 2020: -915.7%FY 2021: -1214.7%FY 2022: -418.7%FY 2023: -468.1%FY 2024: -1027.8%FY 2025: 5387.3%
FY 2009 5y median -468.1% FY 2025

Growth (YoY)

Revenue -30.0%
FY 2009: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 13.7%FY 2025: -30.0%
FY 2009 FY 2025
Operating Income -17.1%
FY 2009: -4075.1%FY 2017: 0.0%FY 2018: -3428.9%FY 2019: 3.3%FY 2020: -4.5%FY 2021: -11.2%FY 2022: -42.1%FY 2023: 55.7%FY 2024: 47.7%FY 2025: -17.1%
FY 2009 FY 2025
EPS (diluted) 120.0%
FY 2009: -1531311.6%FY 2017: 0.0%FY 2018: 35.5%FY 2019: 72.3%FY 2020: -150.0%FY 2021: 48.7%FY 2022: 85.7%FY 2023: 45.5%FY 2024: -25.0%FY 2025: 120.0%
FY 2009 FY 2025
Free Cash Flow 17.0%
FY 2009: -3561.3%FY 2017: 0.0%FY 2018: -4048.9%FY 2019: 50.4%FY 2020: -18.2%FY 2021: 66.1%FY 2022: -107.0%FY 2023: 82.7%FY 2024: 62.0%FY 2025: 17.0%
FY 2009 FY 2025

Financial Health

Current Ratio 0.0×
FY 2009: 0.0×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2009 5y median 0.0× FY 2025
Quick Ratio 0.0×
FY 2009: 0.0×FY 2017: 6.2×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2009 5y median 0.0× FY 2025
Debt / Equity -0.1×
FY 2009: -0.2×FY 2017: -0.2×FY 2018: -0.0×FY 2019: -0.1×FY 2020: -0.2×FY 2021: -0.2×FY 2022: -0.2×FY 2023: -0.2×FY 2024: -0.1×FY 2025: -0.1×
FY 2009 5y median -0.2× FY 2025
Net Debt / EBITDA -1.2×
FY 2009: -0.0×FY 2017: 0.0×FY 2018: 0.4×FY 2019: 2.2×FY 2020: -0.5×FY 2021: -0.1×FY 2022: 1.4×FY 2023: 14.3×FY 2024: 1956×FY 2025: -1.2×
FY 2009 5y median 1.4× FY 2025
Interest Coverage -6.9×
FY 2009: 0.0×FY 2017: 0.0×FY 2018: -173×FY 2019: -5.3×FY 2020: -1.1×FY 2021: -1.0×FY 2022: -22.6×FY 2023: -3.9×FY 2024: -7.5×FY 2025: -6.9×
FY 2009 5y median -6.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2009: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2009 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2009: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2009 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30